SanegeneBio raises $110m for RNAi, plus other financings Biotech financings this week include SanegeneBio's Lilly-backed $110m Series B, with Sidera, D3 Bio, BlossomHill, and Prolynx also raising new funds.

#RNAinterference drug developer #SanegeneBio leads our round-up of this week's #biotechfinancings, with a $110 million Series B backed by recent partner #EliLilly.

pharmaphorum.com/news/sanegen...